Author

J. H. Grosset

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

D. Almeida· 1 shared E. Nuermberger· 1 shared E. Nuermburger· 1 shared J. Lee· 1 shared N. C. Ammerman· 1 shared P. J. Converse· 1 shared R. Chaisson· 1 shared R. Tasneen· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

D. Almeida

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivFeb 21, 2019

Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis

V. Saini, N. C. Ammerman, Y. S. Chang…·J. H. Grosset

This study tests a new TB treatment regimen combining high-dose rifapentine and clofazimine in mouse models, finding it more effective than either drug alone in shortening treatment duration.

DOI 10.1128/aac.00388-19

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivAug 19, 2018

High-dose rifamycins enable shorter oral treatment in a murine model of Mycobacterium ulcerans disease

T. F. Omansen, D. Almeida, P. J. Converse…·E. Nuermberger

This study evaluates higher doses of rifamycins in a mouse model of Buruli ulcer, finding dose-dependent efficacy and potential for shorter treatment regimens.

DOI 10.1128/aac.01478-18

mouseexperimental assay

𝕏 PostBluesky